Represents shares of common stock issuable pursuant to restricted stock units which vested on July 18, 2012 as a result of the issuer's receipt of marketing authorization of ILUVIEN in at least four of the seven EU countries in which ILUVIEN has been recommended for marketing authorization.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.